Avapritinib approved by FDA for use in systemic mastocytosis
On June 16, 2021, the FDA approved a new targeted drug for advanced systemic mastocytosis, a group of rare...
On June 16, 2021, the FDA approved a new targeted drug for advanced systemic mastocytosis, a group of rare...
The SGLT2 inhibitors, or gliflozins, have been rising stars in the fields of endocrinology and cardiology for their ability...
Flow cytometry is a technique in which tens of thousands of cells are passed through a fluidics system, and...